TY - CHAP M1 - Book, Section TI - Arterial Disease A1 - Lin, Peter H. A1 - Bechara, Carlos F. A1 - Chen, Changyi A1 - Veith, Frank J. A2 - Brunicardi, F. Charles A2 - Andersen, Dana K. A2 - Billiar, Timothy R. A2 - Dunn, David L. A2 - Kao, Lillian S. A2 - Hunter, John G. A2 - Matthews, Jeffrey B. A2 - Pollock, Raphael E. Y1 - 2019 N1 - T2 - Schwartz's Principles of Surgery, 11e AB - Key Points Carotid intervention as a preventive strategy should be performed in patients with 60% or greater symptomatic internal carotid artery stenosis and those with 80% or greater asymptomatic internal carotid artery stenosis. Carotid intervention for asymptomatic stenosis between 60% and 79% remains controversial. The modality of carotid intervention—carotid endarterectomy versus carotid stenting—remains controversial; currently, carotid endarterectomy appears to be associated with lower stroke rate with long term durability, whereas carotid stenting is more suitable under certain challenging anatomic or physiologic conditions. Abdominal aortic aneurysms should be repaired when the risk of rupture, determined mainly by aneurysm size, exceeds the risk of death due to perioperative complications or concurrent illness. Endovascular repair is associated with less perioperative morbidity and mortality compared with open reconstruction and is preferred in patients with suitable anatomic morphology for stent-graft placement. Treatment objectives for symptomatic mesenteric ischemia are to improve quality of life and prevent bowel infarction. Endovascular intervention with stenting has similar treatment efficacy comparative with less perioperative morbidity compared to open mesenteric bypass. Surgical reconstruction has a proven durability and patency rate compared with endovascular intervention. Aortoiliac occlusive disease can be treated with either endovascular means or open reconstruction, depending on patient risk stratification, occlusion characteristics, and symptomatology. Claudication is a marker of extensive atherosclerosis and is mainly managed with risk factor modification and pharmacotherapy. Only 5% of patients with claudication will need intervention because of disabling extremity pain. The 5-year mortality of a patient with claudication approaches 30%. Patients with rest pain or tissue loss need expeditious evaluation and vascular reconstruction to ameliorate the severe extremity pain and prevent limb loss. Endovascular intervention is preferred as the first line of therapy for lower extremity occlusive disease, whereas bypass reconstruction should be considered in failed endovascular therapy or long segment femoropopliteal occlusive disease. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/10/12 UR - accesssurgery.mhmedical.com/content.aspx?aid=1164312731 ER -